EP Patent

EP0349204A3 — Use and regeneration of reagents using coupled reactions and permselective barriers

Assigned to Bend Research Inc · Expires 1991-08-07 · 35y expired

What this patent protects

A process is disclosed for the use and regeneration of valuable reagents, including coenzymes, using permselective barrier-assisted coupled reactions, most involving redox couples.

USPTO Abstract

A process is disclosed for the use and regeneration of valuable reagents, including coenzymes, using permselective barrier-assisted coupled reactions, most involving redox couples.

Drugs covered by this patent

sapropterin-dihydrochloride (SAPROPTERIN DIHYDROCHLORIDE)

Patent Metadata

Patent number: EP0349204A3
Jurisdiction: EP
Classification: —
Expires: 1991-08-07
Drug substance claim: No
Drug product claim: No
Assignee: Bend Research Inc
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.